Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Retatrutide is a difficult molecule to synthesise to 99%+ purity and a vial advertised at a fraction of the going rate is often a vial of an older, easier-to-synthesise GLP-1 or GIP/GLP-1 analogue with a retatrutide label on it
The GLP-1 receptor agonist market size was exhibited at USD 36.95 billion in 2023 and is projected to hit around USD 261.19 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2024 to 2033
the elderly, strict vegetarians (i.e., vegan), and patients with malabsorption problems are more likely to become deficient
Reduced food intake over months of treatment can lead to deficiencies
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
